Europe - Euronext Paris - EPA:BOI - FR0000061129 - Common Stock
The current stock price of BOI.PA is 30.35 EUR. In the past month the price increased by 0.5%. In the past year, price increased by 19.25%.
ChartMill assigns a technical rating of 7 / 10 to BOI.PA. When comparing the yearly performance of all stocks, BOI.PA is one of the better performing stocks in the market, outperforming 76.78% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to BOI.PA. BOI.PA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
Over the last trailing twelve months BOI.PA reported a non-GAAP Earnings per Share(EPS) of 1.12. The EPS decreased by -18.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.84% | ||
| ROA | 3.45% | ||
| ROE | 5.25% | ||
| Debt/Equity | 0.04 |
For the next year, analysts expect an EPS growth of 5.53% and a revenue growth 2.95% for BOI.PA
Boiron SA engages in the manufacturing and selling homeopathic medicines. The company is headquartered in Rontalon, Auvergne-Rhone-Alpes and currently employs 2,736 full-time employees. The firm develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. The company also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.
BOIRON SA
2 avenue de l ouest Lyonnais
Rontalon AUVERGNE-RHONE-ALPES FR
Employees: 2788
Phone: 33478456100
Boiron SA engages in the manufacturing and selling homeopathic medicines. The company is headquartered in Rontalon, Auvergne-Rhone-Alpes and currently employs 2,736 full-time employees. The firm develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. The company also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.
The current stock price of BOI.PA is 30.35 EUR. The price decreased by -0.98% in the last trading session.
BOIRON SA (BOI.PA) has a dividend yield of 3.97%. The yearly dividend amount is currently 1.35.
BOI.PA has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
BOI.PA stock is listed on the Euronext Paris exchange.
The PE ratio for BOIRON SA (BOI.PA) is 27.1. This is based on the reported non-GAAP earnings per share of 1.12 and the current share price of 30.35 EUR.
You can find the ownership structure of BOIRON SA (BOI.PA) on the Ownership tab.